Changeflow GovPing Healthcare Vibrent Health, NIH award, $16.5M unallowable c...
Routine Notice Added

Vibrent Health, NIH award, $16.5M unallowable costs

Favicon for oig.hhs.gov HHS OIG Reports
Detected
Email

Summary

Vibrent Health, NIH award, $16.5M unallowable costs

Archived snapshot

Apr 4, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Vibrent Health Claimed Unallowable Costs Under a National Institutes of Health Other Transaction Award

Issued on

04/02/2026

| Posted on

04/03/2026

| Report number: A-04-24-02049


Report Materials

Why OIG Did This Audit

  • The National Institutes of Health is one of a small number of Federal agencies with authority to use other transactions (OTs), which is a special award instrument not generally subject to Federal laws and regulations that apply to traditional awards. Between 2016 and 2023, NIH awarded more than $5.3 billion in OTs. Although OTs are subject to fewer restrictions than contracts, grants, or cooperative agreements, they must be awarded and administered in a way that ensures proper stewardship of Federal funds.
  • Prior OIG work identified weaknesses in NIH’s processes for determining whether costs incurred under OT awards were allowable.
  • This audit examined the allowability of costs that Vibrent Health claimed for information technology services provided through NIH’s All of Us Research Program.

What OIG Found

  • From August 2020 through December 2023, Vibrent Health claimed $161.2 million for reimbursement under the OT award, of which no more than $144.7 million was allowable.
  • The remaining $16.5 million included $1.9 million of unapproved fringe benefit and indirect costs and at least $14.6 million of unreasonable subcontract costs.

What OIG Recommends

We recommend that Vibrent Health work with NIH to determine the allowability of the at least $16.5 million in unapproved and unreasonable costs and refund costs deemed unallowable. We also recommend that Vibrent Health create an oversight function to ensure compliance with the terms and conditions of future Federal awards.

Vibrent Health did not indicate concurrence or nonconcurrence with our recommendations; however, it disagreed with our findings.

Report Type Audit HHS Agencies National Institutes of Health Issue Areas Financial Stewardship Target Groups – Financial Groups Other Funding

Notice

This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.

Get daily alerts for HHS OIG Reports

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from HHS OIG.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
HHS OIG
Instrument
Notice

Get alerts for this source

We'll email you when HHS OIG Reports publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!